Slow Capital’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
NAMA
Slow Capital's TXG Position: Q1 2025 in Review
Slow Capital sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 21,584 shares — an estimated $310K sold.
Slow Capital first reported a position in TXG in Q3 2020 and held it in 18 quarters. The position peaked at $4.02M in Q1 2023. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.
- Slow Capital reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
- Slow Capital sold 21,584 10x Genomics shares in Q1 2025, an estimated $310K.
- Slow Capital first reported a position in 10x Genomics in Q3 2020 and held it in 18 quarters.
- Slow Capital's 10x Genomics position peaked at $4.02M in Q1 2023.
- 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.
Based on Slow Capital's 13F filing for Q1 2025, filed 2 May 2025.